In NAFLD mouse models, hyperactivation of the mTOR pathway upregulates hepatic CD36 expression, exacerbating lipid deposition (Wang et al., 2014). This evidence concerns the gene MTOR and metabolic dysfunction-associated steatotic liver disease.